Skip to main content

Therapeutic Effect of Tamoxifen Related to Estrogen Receptor Level

  • Chapter
Endocrine Treatment of Breast Cancer

Abstract

The antioestrogen tamoxifen (TAM) has been shown to be an effective compound in the endocrine therapy of postmenopausal patients with advanced breast cancer. The overall remission rate observed has been found to be 35%–45% in several studies, depending on whether patients have previously received endocrine therapy (Kiang and Kennedy, 1977; Mouridsen, et al., 1978; Moseson, et al., 1978). This value compares well with that found with other modes of endocrine therapy. A definite advantage of TAM treatment over other forms of endocrine therapy is that side effects are very few and are mild in character (Mouridsen et al., 1978).

Workers at the Fibiger Laboratory were sponsored by the Danish Cancer Society.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Dæhnfeldt, J. L., Briand, P.: Determinations of high-affinity gestagen receptors in hormone-responsive and hormone-independent GR mouse mammary tumors by an exchange assay. In: Progesterone receptors in normal and neoplastic tissues. McGuire, W. L., Raynaud, J. P., Baulien, E.-E. (eds.), p. 59. New York: Raven Press 1977

    Google Scholar 

  • Hayward, J. L., Carbone, P. P., Heuson, J.-C., Kumaoka, S., Segaloff, A., Reubens, R. D.: Assessment of response to therapy in advanced breast cancer. Eur. J. Cancer 13, 89–94 (1977)

    Google Scholar 

  • Heuson, J. C., Longeval, E., Mattheiem, W. H., Deboel, M. C., Sylvester, R. J., Leclercq, G.: Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer. Cancer 39, 1971–1977 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Horwitz, K. V., McGuire, W. L.: Estrogen and progesterone: their relationship in hormone-dependent breast cancer. In: Progesterone receptors in normal and neoplastic tissues. McGuire, W. L. et al. (eds.), p. 103. New York: Raven Press 1977

    Google Scholar 

  • Jensen, E. V.: Estrogen receptors in hormone-dependent breast cancers. Cancer Res. 35, 3362–3364 (1975)

    PubMed  CAS  Google Scholar 

  • Jensen, E. V., Block, G. E., Smith, S., Kyser, K., Desombre, E. R.: Estrogen receptors and breast cancer response to adrenalectomy. Natl. Cancer Inst. Monogr. 34, 55–70 (1971)

    PubMed  CAS  Google Scholar 

  • Jensen, E. V., Polley, T. Z., Smith, S., Block, G. E., Ferguson, D. J., Desombre, E. R.: Prediction of hormone dependency in human breast cancer. In: Estrogen receptors in human breast cancer., McGuire, W. L., Carbone, P. P., Vollmer, E. P. (eds.), p. 37. New York: Raven Press 1975

    Google Scholar 

  • Kiang, D. T., Kennedy, B. J.: Tamoxifen (antiestrogen) therapy in advanced breast cancer. Ann. Intern. Med. 87, 687–690 (1977)

    PubMed  CAS  Google Scholar 

  • Laing, L., Smith, M. G., Calman, K. C., Smith, D. C., Leake, R. E.: Nuclear oestrogen receptors and treatment of breast cancer. Lancet 1977 II, 168–169

    Article  Google Scholar 

  • Lippman, M. E., Allegra, J. C., Thompson, E. B., Simon, R., Barlock, A., Green, L., Huff, K. K., Do, H. M. T., Aitken, S. C., Warren, R.: The relation between estrogen receptors and respone rate to cytotoxic chemotherapy in metastatic breast cancer. N. Engl. J. Med. 298, 1223–1228 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Maass, H., Engel, B., Trams, G.: Steroid hormone receptors in human breast cancer and the clinical significance. J. Steroid Biochem. 6, 743–749 (1975)

    Article  PubMed  CAS  Google Scholar 

  • McGuire, W. L., Pearson, O. H., Segaloff, A.: Predicting hormone responsiveness in human breast cancer. In: Estrogen receptors in human breast cancer. McGuire, W. L., Carbone, P. P., Vollmer, E. P. (eds.), p. 17. New York: Raven Press 1975

    Google Scholar 

  • Morgan, L. R., Jr., Schein, P. S., Woolley, P. V., Hoth, D., Macdonald, J., Lippmann, M., Posey, L. E., Beazley, R. W.: Therapeutic use of tamoxifen in advanced breast cancer: Correlation with biochemical parameters. Cancer Treat. Rep. 60, 1437–1443 (1976)

    PubMed  Google Scholar 

  • Moseson, D. L., Sasaki, G. H., Kraybill, W. G., Leung, B. S., Davenport, C. E., Fletcher, W. S.: The use of antiestrogens, tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values. Cancer 41, 797–800 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Mouridsen, H. T., Palshof, T., Patterson, J., Battersby, L.: Tamoxifen — a review of its efficacy in advanced breast cancer. Cancer Treat. Rev. 5, 131–141 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Mouridsen, H. T., Palshof, T., Rose, C.: Therapeutic effect of tamoxifen alone versus tamoxifen in combination with gestagen or estrogen in advanced breast cancer. In: Endocrine treatment of breast cancer — A new approach. Henningsen, B., Linder, F., Steichele, C. (eds.), p. 169–177. Berlin, Heidelberg, New York: Springer 1980

    Google Scholar 

  • Nenci, I., Beccati, M. D., Piffanelli, A., Lanza, G.: Detection and dynamic localisation of estradiol-receptor complexes in intact target cells by immunofluorescence technique. J. Steroid Biochem. 7, 505–510 (1976)

    Article  PubMed  CAS  Google Scholar 

  • Pertschuk, L. P.: Detection of estrogen binding in human mammary carcinoma by immunofluorescence: a new technique utilizing the binding hormone in a polymerized state. Res. Commun. Chem. Pathol. Pharmacol. 14, 771–114 (1976)

    PubMed  CAS  Google Scholar 

  • Savlov, E. D., Wittliff, J. L., Hilf, R.: Further studies of biochemical predictive tests in breast cancer. Cancer 39, 539–541 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Sluyser, M., Van Nie, R.: Estrogen receptor content and hormone-responsive growth of mouse mammary tumors. Cancer Res. 34, 3253–3257 (1974)

    PubMed  CAS  Google Scholar 

  • Tormey, D. C., Simon, R. M., Lippman, M. E., Bull, J. M., Myers, C. E.: Evaluation of tamoxifen dose in advanced breast cancer: A progress report. Cancer Treat. Rep. 60, 1451–1459 (1976)

    PubMed  CAS  Google Scholar 

  • Ward, W. W. C.: Combined antiprolactin and antiestrogen therapy for breast carcinoma. Clin. Oncol. 3, 91–95 (1977)

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Rose, C., Thorpe, S.M., Løber, J., Dænfeldt, J.L., Palshof, T., Mouridsen, H.T. (1980). Therapeutic Effect of Tamoxifen Related to Estrogen Receptor Level. In: Henningsen, B., Linder, F., Steichele, C. (eds) Endocrine Treatment of Breast Cancer. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 71. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81406-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81406-8_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81408-2

  • Online ISBN: 978-3-642-81406-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics